ClinicalTrials.gg
Drug

Fingolimod clinical trials

Also written FTY720 and Gilenya.

studies test it
75
open now
7
in phase 3
24
first study started
2002

How each study uses fingolimod is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the fingolimod studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
21 Sept 2010 · GILENYA · NDA 022527 (FDA, Drugs@FDA)
European Union
17 Mar 2011 · Gilenya · EMEA/H/C/002202 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Fingolimod
43
Fingolimod 0.5 mg
5
Fingolimod Hydrochloride
3
fingolimod (FTY720)
3
Fingolimod 1.25 mg
3

Brand

Gilenya
17

Development codes

FTY720
31

Studies by the year they started

75 studies that test it; most in 2012 (9)

Studies that test fingolimod, by start year
YearStudies
20021
20034
20044
20052
20064
20071
20085
20104
20116
20129
20139
20143
20153
20162
20172
20192
20205
20213
20222
20231
20251
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
7
Phase 2
21
Phase 3
24
Phase 4
23
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 54 · Other 21

Novartis Pharmaceuticals (38) · Novartis (12) · Mayo Clinic (2) · Second Affiliated Hospital, School of Medicine, Zhejiang University (2) · Wake Forest University Health Sciences (1) · Alembic Pharmaceuticals Ltd. (1) · Genuine Research Center, Egypt (1) · Indiana University (1)

Often tested with

Tested in the same studies.

Dimethyl Fumarate (2) · Mycophenolic Acid (1) · Diroximel fumarate (1) · Ublituximab (1) · Natalizumab (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 3 phase 3 studies under way

Fingolimod is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 2

Studies that test fingolimod.

Studies

Open first, then newest update. How each study uses fingolimod is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 75

See all 75 studies that test fingolimod →

Given beside what is tested · 2 — fingolimod is usual care or a partner of the new treatment
As the comparator · 5 — what is tested is compared with fingolimod

Codes

What other systems call fingolimod · ClinicalTrials.gg INT006551

  • MeSH (NLM) D000068876Fingolimod HydrochlorideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 3QN8BYN5QFFINGOLIMODConfirmed FDA, NLM, Wikidata
  • RxNorm 1012892Confirmed FDA, Wikidata
  • Wikidata Q425137fingolimodConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C74202FingolimodOne source FDA
  • DrugBank DB08868One source Wikidata

Also registered as fingolimod hydrochloride (UNII G926EC510T · RxNorm 1012891).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.